newsfilter
← Latest News
Business Wire·

Elan’s Response to Royalty Pharma Announcement

DUBLIN--(BUSINESS WIRE)--The Board of Elan Corporation, plc (NYSE:ELN) (Elan) notes today’s announcement regarding the revised offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire Elan's shares under Rule 2.5 of the Irish Takeover Rules.